Comparison between repaglinide plus metformin vs glimepiride plus metformin on glucose metabolism and lipoprotein (a) in type 2 diabetic patients: A 1-year study

被引：0
|
作者：
Ciccarelli, L
Derosa, G
Mugellini, A
Boschi, D
Ghelfi, M
Fogari, R
机构：
来源：
DIABETES | 2003年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A458 / A458
页数：1
相关论文
共 50 条
  • [21] Effects of metformin plus gliclazide compared with metformin alone on circulating endothelial progenitor cell in type 2 diabetic patients
    Lu-lu Chen
    Yun-fei Liao
    Tian-shu Zeng
    Fan Yu
    Hui-qing Li
    Yong Feng
    Endocrine, 2010, 38 : 266 - 275
  • [22] The minimal blood glucose variability is observed in type 2 diabetic patients on metformin plus DPP-IV inhibitors
    Smirnov, I. I.
    Zhuravlyova, L. V.
    Ilchenko, I. A.
    DIABETOLOGIA, 2011, 54 : S340 - S340
  • [23] Dapagliflozin plus saxagliptin plus metformin triple therapy vs sitagliptin add-on to metformin dual therapy in subgroups of patients with uncontrolled type 2 diabetes
    Del Prato, S.
    Handelsman, Y.
    Mathieu, C.
    Johnsson, E.
    Kurlyandskaya, R.
    Iqbal, N.
    Garcia-Sanchez, R.
    Rosenstock, J.
    DIABETOLOGIA, 2017, 60 : S20 - S21
  • [24] Comparison between repaglinide and glipizide in Type 2 diabetes mellitus: a 1-year multicentre study
    Madsbad, S
    Kilhovd, B
    Lager, I
    Mustajoki, P
    Dejgaard, A
    DIABETIC MEDICINE, 2001, 18 (05) : 395 - 401
  • [25] Long-term cost-effectiveness analysis of repaglinide plus metformin versus nateglinide plus metformin in type 2 diabetes patients with inadequate glycemic control on monotherapy: A Finnish analysis
    Valentine, W
    Munro, V
    Brandt, AS
    Ray, J
    Roze, S
    Foos, V
    Palmer, A
    VALUE IN HEALTH, 2006, 9 (03) : A34 - A34
  • [26] A COMPARATIVE STUDY REGARDING EFFICACY & SAFETY BETWEEN ADD-ON PIOGLITAZONE & METFORMIN IN TYPE II DIABETIC PATIENTS NOT CONTROLLED WITH GLIMEPIRIDE AND METFORMIN COMBINATION
    Das, Abhijit
    Chaki, Tanmoy
    Ganguly, Avijit
    Mukherjee, Apurba Kumar
    Das, Anup Kumar
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2015, 4 (81): : 14107 - 14114
  • [27] A comparision of the efficacy of pioglitazone plus sulphonylurea with metformin plus sulphonylurea over one year in patients with type 2 diabetes
    Maher, L
    Edwards, G
    Lee, C
    Tan, M
    Herz, M
    DIABETES, 2003, 52 : A451 - A451
  • [28] Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea
    Triplitt, Curtis
    Glass, Leonard
    Miyazaki, Yoshiniro
    Wajcberg, Estela
    Gastaldelli, Amalia
    De Filippis, Elena
    Cersosimo, Eugenio
    DeFronzo, Ralph A.
    DIABETES CARE, 2006, 29 (11) : 2371 - 2377
  • [29] Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add-on to metformin in patients with type 2 diabetes
    Mueller-Wieland, Dirk
    Kellerer, Monika
    Cypryk, Katarzyna
    Skripova, Dasa
    Rohwedder, Katja
    Johnsson, Eva
    Garcia-Sanchez, Ricardo
    Kurlyandskaya, Raisa
    Sjostrom, C. David
    Jacob, Stephan
    Seufert, Jochen
    Dronamraju, Nalina
    Csomos, Katalin
    DIABETES OBESITY & METABOLISM, 2018, 20 (11): : 2598 - 2607
  • [30] Treatment of endothelial dysfunction with glimepiride plus metformin in patients with type 2 diabetes mellitus: evaluation with positron emission tomography
    Alexanderson, E.
    Alexanderson, G.
    Sierra, C.
    Cruz, P.
    Talayero, J.
    Garcia-Rojas, L.
    Rodriguez, M.
    Meave, A.
    DIABETOLOGIA, 2007, 50 : S483 - S483
12345